The Development of Differentiation Agents for the Treatment of Prostate Cancer

Keyphrases

• Prostate Cancer 100%
• Differentiating Agents 100%
• Oncology 50%
• Trial Design 50%
• Histone Deacetylase Inhibitor (HDACi) 50%
• Disease States 50%
• Toxicity Profile 50%
• Vitamin D 50%
• Peroxisome Proliferator-activated Receptor 50%
• Retinoids 50%
• Clinical Activity 50%
• Full Potential 50%
• Validation Metrics 50%
• Novel Mechanism of Action 50%
• Potent Drugs 50%
• Therapeutic Class 50%
• Selective Drugs 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Prostate Cancer 100%
• Histone Deacetylase Inhibitor 50%
• Vitamin D 50%
• Retinoid 50%
• Peroxisome Proliferator Activated Receptor Gamma 50%
• Diseases 50%